secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-11-04T21:06:47+00:00
Accession:  0001801170-26-000291
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Clover Health Q3 revenue $759M (+53%), net income $6M; raises FY26 guidance; names permanent CFO
--------------------------------------------------------------------------------

- Q3 2026 net income $6.4M vs $(24.4)M loss a year ago; revenue $759.3M, +52.9% YoY; gross profit $129.8M, +77.3%; adjusted EBITDA $16.1M.
- Medicare Advantage membership 158,907, up 45% YoY; average 158,383 (+46.3%); BER 91.1% vs 93.5%; ~98% of members in PPO rated 5 Stars for PY2028.
- FY2026 guidance raised: revenue $2.97-3.00B, GAAP net income $25-35M, gross profit $540-555M, adjusted EBITDA $75-85M, average MA membership 157,000-158,000.
- Board named interim CFO Joseph Clay Thornton permanent CFO effective Nov 4, 2026; salary $450,000, target bonus 75%, $1.5M RSU grant.
- Joseph Frank Oldakowski named Chief Accounting Officer effective Nov 4, 2026; salary $410,000, target bonus 50%, $850,000 RSU grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/0001801170-26-000291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000291/clov-20261102.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer